We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+11.07%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$48.8B
AUM Growth
+$7.31B
(+18%)
Cap. Flow
+$2.97B
Cap. Flow
% of AUM
6.1%
Top 10 Holdings %
Top 10 Hldgs %
18.45%
Holding
760
New
71
Increased
309
Reduced
252
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$305M |
| 2 |
CVS Health
CVS
|
+$190M |
| 3 |
Novartis
NVS
|
+$175M |
| 4 |
Broadcom
AVGO
|
+$154M |
| 5 |
Western Digital
WDC
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$260M |
| 2 |
UnitedHealth
UNH
|
+$217M |
| 3 |
United Parcel Service
UPS
|
+$140M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$137M |
| 5 |
McKesson
MCK
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.38% |
| 2 | Healthcare | 15.25% |
| 3 | Technology | 13.09% |
| 4 | Industrials | 10.62% |
| 5 | Energy | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANDV
201
DELISTED
Andeavor
ANDV
| $42.5M | 0.09% |
726,796
+358,468
| +97% | +$18.6M |
|
|
OPLN
202
Openlane
OPLN
$4.17B
| $42.4M | 0.09% |
3,791,516
-131,548
| -3% | -$1.43M |
|
|
JWN
203
DELISTED
Nordstrom
JWN
| $41.3M | 0.08% |
668,985
+16,912
| +3% | +$1.02M |
|
|
WR
204
DELISTED
Westar Energy Inc
WR
| $41.3M | 0.08% |
1,284,889
+388,018
| +43% | +$12.2M |
|
|
PHH
205
DELISTED
PHH Corporation
PHH
| $41M | 0.08% |
1,682,841
-26,585
| -2% | -$639K |
|
|
MDRX
206
DELISTED
Veradigm Inc. Common Stock
MDRX
| $40.1M | 0.08% |
2,591,728
-157,457
| -6% | -$2.32M |
|
207
Coca-Cola Europacific Partners
CCEP
$46.5B
| $39.6M | 0.08% |
897,612
+204,766
| +30% | +$8.55M |
|
|
FWLT
208
DELISTED
FOSTER WHEELER AG (SWITZERLAND)
FWLT
| $39.6M | 0.08% |
1,198,076
-83,390
| -7% | -$2.44M |
|
209
Ventas
VTR
$48.9B
| $39M | 0.08% |
595,696
-42,197
| -7% | -$2.93M |
|
210
Moody's
MCO
$81.7B
| $38.3M | 0.08% |
487,718
+5,895
| +1% | +$432K |
|
211
Kosmos Energy
KOS
$1.56B
| $36.4M | 0.07% |
3,252,069
+716,074
| +28% | +$7.66M |
|
212
Arch Capital
ACGL
$36.1B
| $36.1M | 0.07% |
1,814,007
+413,781
| +30% | +$7.94M |
|
213
Abercrombie & Fitch
ANF
$4.17B
| $35.6M | 0.07% |
1,082,414
+104,173
| +11% | +$3.59M |
|
|
WNR
214
DELISTED
Western Refining Inc
WNR
| $35.3M | 0.07% |
+831,885
| New | +$29.9M |
|
215
Nu Skin
NUS
$247M
| $34.9M | 0.07% |
252,719
-146,201
| -37% | -$17.2M |
|
216
Chemed
CHE
$6.78B
| $34.4M | 0.07% |
448,969
-237,117
| -35% | -$17.5M |
|
|
WAC
217
DELISTED
Walter Investment Mgt Corp
WAC
| $34.3M | 0.07% |
970,865
+351,806
| +57% | +$13.3M |
|
|
MW
218
DELISTED
THE MENS WAREHOUSE INC
MW
| $34.2M | 0.07% |
669,369
-839,398
| -56% | -$39.1M |
|
219
Belden
BDC
$4B
| $33.9M | 0.07% |
481,090
-11,476
| -2% | -$776K |
|
|
VAL
220
DELISTED
Valspar
VAL
| $33.8M | 0.07% |
+474,661
| New | +$32.9M |
|
|
CLNY
221
DELISTED
Colony Capital, Inc.
CLNY
| $33.8M | 0.07% |
1,666,566
-84,345
| -5% | -$1.7M |
|
222
Live Nation Entertainment
LYV
$41.2B
| $33.6M | 0.07% |
1,700,469
+272,339
| +19% | +$5.1M |
|
|
NCI
223
DELISTED
Navigant Consulting, Inc.
NCI
| $33.6M | 0.07% |
1,748,595
-27,993
| -2% | -$497K |
|
224
LSB Industries
LXU
$881M
| $33.6M | 0.07% |
1,063,349
+386,884
| +57% | +$10M |
|
|
CYS
225
DELISTED
CYS Investments Inc.
CYS
| $33.5M | 0.07% |
4,516,055
+2,568
| +0.1% | +$20.6K |
|
Similar funds
Boston Partners's Q4 2013 Portfolio in Review
As of Q4 2013, Boston Partners held 760 positions worth $48.8B, up 18% from $41.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Partners deployed $2.97B of net new capital in Q4 2013, opening 71 new positions and adding to 309 existing holdings. Its largest new stake was Novartis: 2,524,138 shares worth $182M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Halliburton, an estimated $260M trimmed.
- Boston Partners's largest Q4 2013 buy was Novartis: 2,524,138 shares worth $182M.
- Boston Partners added most to ExxonMobil in Q4 2013, an estimated $305M increase.
- Boston Partners's biggest Q4 2013 reduction was Halliburton, cutting an estimated $260M.
- Boston Partners fully exited NVIDIA in Q4 2013, selling an estimated $131M.
- Boston Partners's ten largest holdings make up 18% of its $48.8B portfolio in Q4 2013.
- Boston Partners opened 71 new positions and closed 53 in Q4 2013.
- Boston Partners's portfolio value rose 18% quarter-over-quarter to $48.8B.
Based on Boston Partners's 13F filing for Q4 2013, filed 6 Feb 2014.